CAI - Company ID 0002019410
As of 2026-11-06, Caris Life Sciences, Inc. (CAI) has a market capitalization of $7.12 B, making it the #1127 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-11-06 | $7.12 B |
| 2026-11-05 | $9.53 B |
| 2026-11-04 | $9.39 B |
| 2026-11-03 | $9.28 B |
| 2026-11-02 | $9.11 B |
| 2026-11-01 | $9.70 B |
| 2026-10-31 | $9.70 B |
| 2026-10-30 | $9.60 B |
| 2026-10-29 | $10.15 B |
| 2026-10-28 | $10.02 B |
| 2026-10-27 | $9.52 B |
| 2026-10-26 | $9.17 B |
As of 2026-11-06, Caris Life Sciences, Inc. (CAI) has a market capitalization of $7.12 B, making it the #1127 most valuable US-listed company.
Caris Life Sciences, Inc. is the #1127 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-10-25 | $9.05 B |
| 2026-10-24 | $9.05 B |
| 2026-10-23 | $9.02 B |
| 2026-10-22 | $8.96 B |
| 2026-10-21 | $9.20 B |
| 2026-10-20 | $8.89 B |
| 2026-10-19 | $8.68 B |
| 2026-10-18 | $8.64 B |
| 2026-10-17 | $8.64 B |
| 2026-10-16 | $8.59 B |
| 2026-10-15 | $8.98 B |
| 2026-10-14 | $8.55 B |
| 2026-10-13 | $8.38 B |
| 2026-10-12 | $8.31 B |
| 2026-10-11 | $8.40 B |
| 2026-10-10 | $8.40 B |
| 2026-10-09 | $8.40 B |
| 2026-10-08 | $7.77 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.